186 related articles for article (PubMed ID: 24872695)
1. Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion.
Ding SM; Zhang ZH; Song J; Cheng XD; Jiang J; Jia XB
Int J Nanomedicine; 2014; 9():2327-33. PubMed ID: 24872695
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Bioavailability Study of Baicalin-mesoporous Carbon Nanopowder Solid Dispersion.
Cui L; Sune E; Song J; Wang J; Jia XB; Zhang ZH
Pharmacogn Mag; 2016; 12(48):326-332. PubMed ID: 27867277
[TBL] [Abstract][Full Text] [Related]
3. Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system.
Zhang Z; Cui C; Wei F; Lv H
Drug Dev Ind Pharm; 2017 Aug; 43(8):1276-1282. PubMed ID: 28358225
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles.
Huang Y; Zhao X; Zu Y; Wang L; Deng Y; Wu M; Wang H
Iran J Pharm Res; 2019; 18(1):168-182. PubMed ID: 31089353
[TBL] [Abstract][Full Text] [Related]
5. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
Zhang J; Huang Y; Liu D; Gao Y; Qian S
Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
7. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.
Yang KY; Hwang du H; Yousaf AM; Kim DW; Shin YJ; Bae ON; Kim YI; Kim JO; Yong CS; Choi HG
Int J Nanomedicine; 2013; 8():3333-43. PubMed ID: 24039417
[TBL] [Abstract][Full Text] [Related]
8. Simultaneously Improving the Physicochemical Properties, Dissolution Performance, and Bioavailability of Apigenin and Daidzein by Co-Crystallization With Theophylline.
Huang S; Xue Q; Xu J; Ruan S; Cai T
J Pharm Sci; 2019 Sep; 108(9):2982-2993. PubMed ID: 31029571
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Potential of Mesoporous Silica as a Carrier for Puerarin: Characterization, Physical Stability, and In Vivo Pharmacokinetics.
Wang Z; Ye BN; Zhang YT; Xie JX; Li WS; Zhang HT; Liu Y; Feng NP
AAPS PharmSciTech; 2019 Aug; 20(7):289. PubMed ID: 31414349
[TBL] [Abstract][Full Text] [Related]
10. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of Solubility, Transport Across Madin-Darby Canine Kidney Monolayers and Oral Absorption of Pranlukast Through Preparation of a Pranlukast-Phospholipid Complex.
Hao Y; Wang L; Li J; Liu N; Feng J; Zhao M; Zhang X
J Biomed Nanotechnol; 2015 Mar; 11(3):469-77. PubMed ID: 26307829
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique.
Wu W; Zu Y; Wang L; Wang L; Wang H; Li Y; Wu M; Zhao X; Fu Y
Drug Deliv; 2017 Nov; 24(1):1713-1720. PubMed ID: 29115900
[TBL] [Abstract][Full Text] [Related]
13. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
[TBL] [Abstract][Full Text] [Related]
14. Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: Formulation, characterization and pharmacokinetics.
Islam N; Khan NU; Razzaq A; Menaa F; Khan ZU; Hussain A; Rehman SU; Iqbal H; Ni J
Colloids Surf B Biointerfaces; 2023 Oct; 230():113526. PubMed ID: 37647750
[TBL] [Abstract][Full Text] [Related]
15. Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques.
Alshehri SM; Shakeel F; Ibrahim MA; Elzayat EM; Altamimi M; Mohsin K; Almeanazel OT; Alkholief M; Alshetaili A; Alsulays B; Alanazi FK; Alsarra IA
Saudi Pharm J; 2019 Feb; 27(2):264-273. PubMed ID: 30766439
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
17. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
18. Rubusoside As a Multifunctional Stabilizer for Novel Nanocrystal-Based Solid Dispersions with a High Drug Loading: A Case Study.
Liu Y; Wu Z; Chen Y; Guan Y; Guo H; Yang M; Yue P
J Pharm Sci; 2024 Mar; 113(3):699-710. PubMed ID: 37659720
[TBL] [Abstract][Full Text] [Related]
19. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
20. Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential.
Telange DR; Patil AT; Pethe AM; Fegade H; Anand S; Dave VS
Eur J Pharm Sci; 2017 Oct; 108():36-49. PubMed ID: 27939619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
